Stocks · US
CNC
XNYS
Centene Corporation
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B1.41x
P/S0.16x
EPS$-10.32
ROE-22.60%
ROA-6.14%
Dividend yield0.00%
EV/EBITDA5.24x
Debt/Equity0.71
Free cash flow$9.0B
Returns and 52-week range
1W+3.86%
1M-3.62%
3M-3.70%
6M+77.94%
1Y+66.95%
YTD+54.64%
52W high$69.63
52W low$31.63
From 52W high-7.21%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| DexCom, Inc. | $32.8B | 32.80 | 12.51 | -5.13% |
| 레즈메드 | $31.3B | 20.58 | 4.76 | -3.35% |
| Biogen Inc. Common Stock | $33.0B | 39.58 | 1.75 | +0.93% |
| Alcon Inc. Ordinary Shares | $31.1B | 70.68 | 1.59 | -10.37% |
| BeOne Medicines Ltd. American Depositary Shares | $40.9B | 62.39 | 7.91 | +1.26% |
| Mettler-Toledo International | $30.9B | 34.11 | 2,408.87 | +13.96% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.